These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31311724)

  • 21. Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report.
    Kostos L; Burbury K; Srivastava G; Prince HM
    Platelets; 2015; 26(8):809-11. PubMed ID: 26029798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dasatinib-induced chylothorax: report of a case and review of the literature.
    Chen B; Wu Z; Wang Q; Li W; Cheng D
    Invest New Drugs; 2020 Oct; 38(5):1627-1632. PubMed ID: 32248338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imatinib mesylate- and dasatinib-induced eosinophilia in a patient with chronic myelocytic leukemia.
    McGrath K; Stein B; Kalhagen L; Leighton L
    Ann Allergy Asthma Immunol; 2017 Jul; 119(1):85-86. PubMed ID: 28499700
    [No Abstract]   [Full Text] [Related]  

  • 24. Rapid reduction in BCR-ABL1 transcript predicts deep molecular response in dasatinib-treated chronic-phase chronic myeloid leukaemia patients.
    Murai K; Yamaguchi K; Ito S; Miyagishima T; Shindo M; Wakasa K; Inomata M; Nagashima T; Kondo T; Fujimoto N; Yamamoto S; Yonezumi M; Oyake T; Kowata S; Tsukushi Y; Mine T; Meguro K; Ikeda K; Watanabe R; Saito S; Sato S; Tajima K; Chou T; Kubo K; Oba K; Sakamoto J; Ishida Y;
    Eur J Haematol; 2018 Jan; 100(1):27-35. PubMed ID: 28895203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias.
    Talpaz M; Shah NP; Kantarjian H; Donato N; Nicoll J; Paquette R; Cortes J; O'Brien S; Nicaise C; Bleickardt E; Blackwood-Chirchir MA; Iyer V; Chen TT; Huang F; Decillis AP; Sawyers CL
    N Engl J Med; 2006 Jun; 354(24):2531-41. PubMed ID: 16775234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A Case of Drug-Induced Organizing Pneumonia Caused by Dasatinib].
    Sato M; Watanabe S; Aoki N; Asakawa K; Moriyama H; Oshima Y; Koya T; Okazuka K; Kikuchi T
    Gan To Kagaku Ryoho; 2018 May; 45(5):851-854. PubMed ID: 30026450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dasatinib-associated reversible demyelinating peripheral polyneuropathy in a case of chronic myeloid leukemia.
    Ishida T; Akagawa N; Miyata T; Tominaga N; Iizuka T; Higashihara M; Suzuki T; Miyazaki K
    Int J Hematol; 2018 Mar; 107(3):373-377. PubMed ID: 29027647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of intermittently administered dasatinib with a reduced dose in an elderly patient with chronic myeloid leukemia.
    Imamura M
    Geriatr Gerontol Int; 2016 Jun; 16(6):768-70. PubMed ID: 27246579
    [No Abstract]   [Full Text] [Related]  

  • 29. Dasatinib-induced nephrotic syndrome in a patient with chronic myelogenous leukemia: a case report.
    Ochiai S; Sato Y; Minakawa A; Fukuda A; Fujimoto S
    BMC Nephrol; 2019 Mar; 20(1):87. PubMed ID: 30845905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is dasatinib-related pulmonary hypertension a clinical concern?
    Szmit S
    Future Oncol; 2015 Sep; 11(18):2491-4. PubMed ID: 26278893
    [No Abstract]   [Full Text] [Related]  

  • 31. Dasatinib for the treatment of Philadelphia chromosome-positive chronic myelogenous leukaemia after imatinib failure.
    Hochhaus A
    Expert Opin Pharmacother; 2007 Dec; 8(18):3257-64. PubMed ID: 18035968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium.
    Zwaan CM; Rizzari C; Mechinaud F; Lancaster DL; Lehrnbecher T; van der Velden VH; Beverloo BB; den Boer ML; Pieters R; Reinhardt D; Dworzak M; Rosenberg J; Manos G; Agrawal S; Strauss L; Baruchel A; Kearns PR
    J Clin Oncol; 2013 Jul; 31(19):2460-8. PubMed ID: 23715577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib.
    Oweini H; Otrock ZK; Mahfouz RA; Bazarbachi A
    Arch Gynecol Obstet; 2011 Jan; 283(1):133-4. PubMed ID: 20473616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dasatinib-induced Chylothorax in Chronic Myelogenous Leukemia in Pediatric Patient: Report of a Case and Review of Literature.
    Hickman K; Diaz E; Graham R; Adams R; Ngwube A
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e665-e667. PubMed ID: 31688632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once-daily dasatinib for treatment of patients with chronic myeloid leukemia.
    Tyler T
    Ann Pharmacother; 2009 May; 43(5):920-7. PubMed ID: 19336654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypopigmentation of the Skin and Hair Associated with Dasatinib Therapy.
    Sharma V; Bagrodia V
    Turk J Haematol; 2024 May; 41(2):116-117. PubMed ID: 37698254
    [No Abstract]   [Full Text] [Related]  

  • 37. Dasatinib-related Follicular Hyperplasia: An Underrecognized Entity With Characteristic Morphology.
    Ozawa MG; Ewalt MD; Gratzinger D
    Am J Surg Pathol; 2015 Oct; 39(10):1363-9. PubMed ID: 26360368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma following tyrosine kinase inhibitor treatment for chronic myelogenous leukemia.
    Kojima M; Nakamura N; Amaki J; Numata H; Miyaoka M; Motoori T; Matsumoto K; Ando K
    J Clin Exp Hematop; 2017; 57(2):69-73. PubMed ID: 29021516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of pleural effusion with an early molecular response in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study.
    Hagihara M; Iriyama N; Yoshida C; Wakita H; Chiba S; Okamoto S; Kawakami K; Takezako N; Kumagai T; Inokuchi K; Ohyashiki K; Taguchi J; Yano S; Igarashi T; Kouzai Y; Morita S; Sakamoto J; Sakamaki H
    Oncol Rep; 2016 Nov; 36(5):2976-2982. PubMed ID: 27665844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-induced pneumonitis associated with imatinib mesylate in a patient with idiopathic pulmonary fibrosis.
    Yamasawa H; Sugiyama Y; Bando M; Ohno S
    Respiration; 2008; 75(3):350-4. PubMed ID: 16449804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.